Role of NADPH oxidase and xanthine oxidase in mediating inducible VT/VF and triggered activity in a canine model of myocardial ischemia

Int J Mol Sci. 2014 Nov 4;15(11):20079-100. doi: 10.3390/ijms151120079.

Abstract

Background: Ventricular tachycardia or fibrillation (VT/VF) of focal origin due to triggered activity (TA) from delayed afterdepolarizations (DADs) is reproducibly inducible after anterior coronary artery occlusion. Both VT/VF and TA can be blocked by reducing reactive oxygen species (ROS). We tested the hypothesis that inhibition of NADPH oxidase and xanthine oxidase would block VT/VF.

Methods: 69 dogs received apocynin (APO), 4 mg/kg intraveneously (IV), oxypurinol (OXY), 4 mg/kg IV, or both APO and OXY (BOTH) agents, or saline 3 h after coronary occlusion. Endocardium from ischemic sites (3-D mapping) was sampled for Rac1 (GTP-binding protein in membrane NADPH oxidase) activation or standard microelectrode techniques. Results (mean±SE, * p<0.05): VT/VF originating from ischemic zones was blocked by APO in 6/10 *, OXY in 4/9 *, BOTH in 5/8 * or saline in 1/27; 11/16 VT/VFs blocked were focal. In isolated myocardium, TA was blocked by APO (10(-6) M) or OXY (10(-8) M). Rac1 levels in ischemic endocardium were decreased by APO or OXY.

Conclusion: APO and OXY suppressed focal VT/VF due to DADs, but the combination of the drugs was not more effective than either alone. Both drugs inhibited ischemic Rac1 with inhibition by OXY suggesting ROS-induced ROS. The inability to totally prevent VT/VF suggests that other mechanisms also contribute to ischemic VT.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Acetophenones / pharmacology
  • Acetophenones / therapeutic use
  • Action Potentials / drug effects
  • Animals
  • Blotting, Western
  • Disease Models, Animal
  • Dogs
  • Female
  • Male
  • Myocardial Ischemia / diagnostic imaging
  • Myocardial Ischemia / drug therapy
  • Myocardial Ischemia / enzymology*
  • Myocardial Ischemia / physiopathology
  • NADPH Oxidases / antagonists & inhibitors
  • NADPH Oxidases / metabolism*
  • Oxypurinol / pharmacology
  • Oxypurinol / therapeutic use
  • Tachycardia, Ventricular / complications
  • Tachycardia, Ventricular / drug therapy
  • Tachycardia, Ventricular / enzymology*
  • Tachycardia, Ventricular / physiopathology
  • Ultrasonography
  • Ventricular Fibrillation / complications
  • Ventricular Fibrillation / drug therapy
  • Ventricular Fibrillation / enzymology*
  • Ventricular Fibrillation / physiopathology
  • Xanthine Oxidase / antagonists & inhibitors
  • Xanthine Oxidase / metabolism*
  • rac1 GTP-Binding Protein / metabolism

Substances

  • Acetophenones
  • acetovanillone
  • Xanthine Oxidase
  • NADPH Oxidases
  • rac1 GTP-Binding Protein
  • Oxypurinol